Clinical trials
Active, not recruiting Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
271 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 16 |
| 2019 | 12 |
| 2020 | 13 |
| 2021 | 23 |
| 2022 | 26 |
| 2023 | 38 |
| 2024 | 31 |
| 2025 | 25 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 271 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Edwards Lifesciences | 6 |
| Brigham and Women's Hospital | 5 |
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
| Novartis Pharmaceuticals | 5 |
| Abramson Cancer Center at Penn Medicine | 4 |
| Herlev and Gentofte Hospital | 4 |
| NYU Langone Health | 4 |
| Oslo University Hospital | 4 |
| Abbott Medical Devices | 3 |
| AstraZeneca | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 271 |
| Heart Diseases | 43 |
| Hypertension | 36 |
| Diabetes Mellitus | 29 |
| Heart Failure | 24 |
| Coronary Artery Disease | 23 |
| Coronary Disease | 21 |
| Obesity | 21 |
| Stroke | 21 |
| Atherosclerosis | 20 |
Trials
Showing 51 to 75 of 271. Each trial links to its page on Pharma Observatory.
171 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.